We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+6.32%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$78.4B
AUM Growth
+$3.85B
(+5.2%)
Cap. Flow
-$180M
Cap. Flow
% of AUM
-0.23%
Top 10 Holdings %
Top 10 Hldgs %
13.07%
Holding
685
New
40
Increased
229
Reduced
367
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Polaris
PII
|
+$376M |
| 2 |
Wells Fargo
WFC
|
+$376M |
| 3 |
Qualcomm
QCOM
|
+$364M |
| 4 |
Centene
CNC
|
+$322M |
| 5 |
Gen Digital
GEN
|
+$302M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$399M |
| 2 |
Steel Dynamics
STLD
|
+$340M |
| 3 |
Bank of America
BAC
|
+$269M |
| 4 |
T-Mobile US
TMUS
|
+$255M |
| 5 |
MasTec
MTZ
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.27% |
| 2 | Industrials | 14.86% |
| 3 | Healthcare | 14.33% |
| 4 | Technology | 13.97% |
| 5 | Consumer Discretionary | 12.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPG
201
DELISTED
Interpublic Group of Companies
IPG
| $107M | 0.14% |
3,279,536
+114,741
| +4% | +$3.67M |
|
202
American Electric Power
AEP
$66.8B
| $106M | 0.13% |
1,250,161
+24,641
| +2% | +$2.12M |
|
203
Willis Towers Watson
WTW
$32B
| $104M | 0.13% |
450,986
+8,708
| +2% | +$2.17M |
|
204
Labcorp
LH
$27.4B
| $102M | 0.13% |
429,858
-322,243
| -43% | -$73.4M |
|
205
Boston Scientific
BSX
$68B
| $102M | 0.13% |
2,379,690
+34,868
| +1% | +$1.47M |
|
206
IQVIA
IQV
$43.2B
| $101M | 0.13% |
418,741
-78,858
| -16% | -$18.2M |
|
207
Jazz Pharmaceuticals
JAZZ
$16.1B
| $99M | 0.13% |
557,032
+8,053
| +1% | +$1.39M |
|
208
United Parcel Service
UPS
$89.9B
| $97.6M | 0.12% |
469,110
+15,800
| +3% | +$3.16M |
|
209
Jabil
JBL
$32.2B
| $96.9M | 0.12% |
1,666,788
-468,589
| -22% | -$25.8M |
|
210
Cognizant
CTSH
$29.4B
| $95.5M | 0.12% |
1,378,246
+45,706
| +3% | +$3.4M |
|
211
Xerox
XRX
$414M
| $95.1M | 0.12% |
4,046,503
-1,087,740
| -21% | -$26.3M |
|
212
Southwest Airlines
LUV
$19.6B
| $88M | 0.11% |
1,657,552
-874,134
| -35% | -$52.4M |
|
213
Insight Enterprises
NSIT
$4.65B
| $86.4M | 0.11% |
865,338
-2,261
| -0.3% | -$229K |
|
214
Arrow Electronics
ARW
$10.5B
| $86.2M | 0.11% |
757,693
+12,901
| +2% | +$1.51M |
|
215
Navient
NAVI
$896M
| $84.1M | 0.11% |
4,361,028
-77,212
| -2% | -$1.33M |
|
|
SYNH
216
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $83.5M | 0.11% |
929,839
-50,448
| -5% | -$4.26M |
|
217
Best Buy
BBY
$17.5B
| $81.5M | 0.1% |
709,178
-1,216,615
| -63% | -$142M |
|
218
Hubbell
HUBB
$24.4B
| $81M | 0.1% |
433,771
+8,350
| +2% | +$1.58M |
|
|
OPLN
219
Openlane
OPLN
$4.32B
| $80.6M | 0.1% |
4,601,908
+255,317
| +6% | +$4.33M |
|
220
Stride
LRN
$3.58B
| $80.2M | 0.1% |
2,514,522
+640,406
| +34% | +$19.1M |
|
221
TD Synnex
SNX
$20.7B
| $79.2M | 0.1% |
651,849
-452,326
| -41% | -$55.6M |
|
222
NetEase
NTES
$78.3B
| $76.9M | 0.1% |
667,835
+21,505
| +3% | +$2.37M |
|
223
Belden
BDC
$4.52B
| $75.9M | 0.1% |
1,503,369
+14,799
| +1% | +$723K |
|
224
EnerSys
ENS
$6.84B
| $75.9M | 0.1% |
777,797
-883,403
| -53% | -$82.4M |
|
225
Evercore
EVR
$11.2B
| $74.8M | 0.1% |
531,684
-3,361
| -0.6% | -$470K |
|
Similar funds
Boston Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Boston Partners held 685 positions worth $78.4B, up 5.2% from $74.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Partners's Q2 2021 filing shows 40 new, 229 increased, 367 reduced and 39 closed positions. Its largest new stake was Polaris: 2,775,896 shares worth $380M. The largest sale was Medtronic, an estimated $399M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.
- Boston Partners's largest Q2 2021 buy was Polaris: 2,775,896 shares worth $380M.
- Boston Partners added most to Wells Fargo in Q2 2021, an estimated $376M increase.
- Boston Partners's biggest Q2 2021 reduction was Medtronic, cutting an estimated $399M.
- Boston Partners fully exited MasTec in Q2 2021, selling an estimated $204M.
- Boston Partners's ten largest holdings make up 13% of its $78.4B portfolio in Q2 2021.
- Boston Partners opened 40 new positions and closed 39 in Q2 2021.
- Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $78.4B.
Based on Boston Partners's 13F filing for Q2 2021, filed 12 Aug 2021.